Building the skull - normal and abnormal development

Lead Research Organisation: University of Oxford
Department Name: RDM Radcliffe Department of Medicine

Abstract

This project will focus on craniosynostosis, the premature fusion of one or more sutures separating the bones of the skull vault. A complex network of developmental mechanisms is involved in patterning and maintaining this complex system of bones, and a variety of genetic mutations can affect these processes to cause serious skull malformations. Oxford is a leading national referral centre in the surgical treatment of these malformations, enabling us study the entire process by which these arise from patient to mutation, and from mouse model to molecular pathogenesis.
The project will exploit the large number of clinical samples available to explore specific hypotheses of causation. An early focus will involve investigation of the gene RUNX2, which encodes a master transcriptional regulator of ossification. There is likely to be the opportunity to interrogate whole genome sequence as part of the research programme of the new NHS Genomic Medicine Service diagnostics service. Potential epigenetic mechanisms of pathogenesis will be explored as well. To investigate pathophysiology, carefully selected mutations will be modelled in mice. We still know very little about what happens biologically in the cranial sutures themselves: these structures must achieve a delicate balancing act of enabling growth of new bone at the margins of the suture, whilst also ensuring that the mid-part of the suture remains open along its entire length. We explore how the suture works by mapping out the cellular hierarchy of activities from undifferentiated stem cell to fully formed osteoblast, comparing results between normal sutures and those from mice with targeted mutations. A specific focus will be to elucidate the pathogenic mechanisms by which craniosynostosis arises in a Zic1-mutated mouse, available in the laboratory. The opportunity to generate additional targeted mouse mutants using CRISPR/Cas9 genome editing may arise out of the human genetics investigations.
Specific skills acquired will include: (i) use of web resources to interpret genomic information from human, mouse and other species; (ii) experimental techniques including cell culture, fluorescence-activated cell sorting (FACS), microscopy, single cell transcriptomics and next generation sequencing, in addition to basic molecular biology methodologies; (iii) training in husbandry and phenotypic analysis of mice, with acquisition of a personal license and (iv) bioinformatics approaches to analysis of large datasets including genome sequencing, single cell transcriptomics, or epigenomics (full support will be available through the Centre for Computational Biology). Additional generic and transferable skills training will be provided through the MRC-WIMM DPhil Course and the Medical Sciences Division's Skills Training Programme.

Publications

10 25 50

Studentship Projects

Project Reference Relationship Related To Start End Student Name
MR/N013468/1 01/10/2016 30/09/2025
2434887 Studentship MR/N013468/1 01/10/2020 30/09/2024 Isaac Walton
 
Description SMAD6 splice site disruption project with researchers from the University of Antwerp, and clinicians from Leeds Teaching Hospitals NHS Trust 
Organisation Leeds Teaching Hospitals NHS Trust
Country United Kingdom 
Sector Public 
PI Contribution I undertook EBV transformation of a patient blood sample, cultured these lymphoblasts, and extracted RNA. Subsequent RT-PCR showed the presence of an aberrantly spliced product in SMAD6, a gene associated with craniosynostosis.
Collaborator Contribution Our collaborators in Leeds initially identified a homozygous variant that disrupted a splice donor site in SMAD6. They arranged for blood to be extracted, and sent to us in Oxford. Our collaborators in Antwerp gave technical advice in relation to analysing the splice products and in drafting the manuscript that describes this case.
Impact We were able to identify an aberrant splice product in the patient where a splice donor site had been disrupted by a homozygous variant. This data has been added to a manuscript that is currently under review.
Start Year 2021
 
Description SMAD6 splice site disruption project with researchers from the University of Antwerp, and clinicians from Leeds Teaching Hospitals NHS Trust 
Organisation University of Antwerp
Department Centre of Medical Genetics
Country Belgium 
Sector Academic/University 
PI Contribution I undertook EBV transformation of a patient blood sample, cultured these lymphoblasts, and extracted RNA. Subsequent RT-PCR showed the presence of an aberrantly spliced product in SMAD6, a gene associated with craniosynostosis.
Collaborator Contribution Our collaborators in Leeds initially identified a homozygous variant that disrupted a splice donor site in SMAD6. They arranged for blood to be extracted, and sent to us in Oxford. Our collaborators in Antwerp gave technical advice in relation to analysing the splice products and in drafting the manuscript that describes this case.
Impact We were able to identify an aberrant splice product in the patient where a splice donor site had been disrupted by a homozygous variant. This data has been added to a manuscript that is currently under review.
Start Year 2021
 
Description ZIC1 Protein Interaction experiment with researchers from the University of Tubingen 
Organisation Eberhard Karls University of Tübingen
Department Institute for Ophthalmic Research
Country Germany 
Sector Academic/University 
PI Contribution Our group undertook mutagenesis reactions on the collaborator-provided P-DESTN backbone plasmid to introduce clinically relevant variants identified in ZIC1 patients recruited to our lab's craniofacial malformations study. Upon getting the results of the SF-TAP experiment undertaken in Tubingen, we used these candidate proteins and the generated protein interaction dataset to source several plasmids for proteins to be used in co-IP experiments to functionally validate these changes in interaction.
Collaborator Contribution Our collaborators provided a backbone plasmid for the SF-TAP technique they developed. Upon being provided with our modified iterations of this, they undertook SF-TAP to determine differences in protein interaction with the varied proteins, as well as data analysis to determine candidate proteins that showed significantly different levels of interaction.
Impact Using the provided P-DESTN constructs, we was able to produce several constructs with different clinically relevant genetic variants which will be useful in subsequent research. We Received SF-TAP protein interaction data for these constructs from our collaborators which has informed further functional studies we plan to carry out to validate certain interactions. This collaboration is multi-disciplinary and utilises our collaborator's expertise in proteomics/SF-TAP, and our lab's human genetics expertise and recruited patients.
Start Year 2021
 
Description ZIC1 clinical report collaboration with clinicians from Oxford University Hospitals NHS Foundation Trust 
Organisation Oxford University Hospitals NHS Foundation Trust
Country United Kingdom 
Sector Academic/University 
PI Contribution Utilising samples sourced from recruited patients in Oxford, I undertook deep sequencing and microsatellite analysis of individuals to evaluate chimerism and paternity in individuals and families with variants in ZIC1.
Collaborator Contribution Clinicians from Oxford Hospitals sourced and recruited patients into our clinical research study, as well as arranged for patient samples to arrive at our lab.
Impact As a result of this, an additional patient family with a ZIC1 variant was screened, with paternity and non-chimerism validated. This was added to a draft manuscript describing the phenotype in ZIC1 craniosynostosis patients.
Start Year 2021
 
Description Lab research showcase: online video and panel 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Public/other audiences
Results and Impact As part of the Oxford Open Doors Programme 2021, the lab created a YouTube video to showcase members' research and the general research theme of the lab. This was streamed during a timed slot in the Open Doors weekly programme attended by roughly 45 people, followed by a panel discussion in which questions were given to the group. This session was advertised to the general public, as well as the patient support charity for the disease we study (Craniosynostosis), and the NHS craniofacial team's clinicians at the local hospital. The video was subsequently uploaded to our Institute's YouTube channel, where it has c.1k views.

Some patients/family members in the audience asked engaging questions and seemed genuinely interested to learn what happened to samples after they left the clinic and the way they were used in our lab. It is hoped the uploaded YouTube video will have increased awareness of Craniosynostosis, as well as the projects our lab is pursuing to elucidate its pathogenesis.
Year(s) Of Engagement Activity 2021
URL https://www.youtube.com/watch?v=LoZUoOF4nLM
 
Description SCiP Alliance Video 
Form Of Engagement Activity Engagement focused website, blog or social media channel
Part Of Official Scheme? No
Geographic Reach Regional
Primary Audience Schools
Results and Impact Took part in a virtual pre-recorded conference for children of service personnel, and educators (SCiP). This included being part of a short video recounting my experience of accessing higher education as the child of a service person, as well as why I'm doing a DPhil, and the scientific work I do as part of that.

The video was well-received and sparked awareness about both accessing higher education, and the science I work on, and has been played at subsequent conferences held by SCiP.
Year(s) Of Engagement Activity 2021,2022
URL https://www.scipalliance.org/events/thriving-lives-toolkit-virtual-training-conference-for-schools-o...